Need for Abuse Deterrent Products

The misuse and abuse of prescription drug products in general, and opioid analgesics in particular, is a significant societal problem that has been described as a top priority by the White House’s Office of National Drug Control Policy and an epidemic in nature by Joseph A. Califano, Jr., Chairman and President, National Center for Addiction and Substance Abuse at Columbia University, July 2005.

Acura’s abuse deterrent technology platforms, LIMITX, IMPEDE® and AVERSION, have potential benefits in combating the abuse of opioid analgesics, non-opioid drugs and nasal decongestants.

  • Opioid Analgesics
  • Nasal Decongestants